Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1989 3
1990 4
1991 7
1992 2
1993 4
1994 2
1998 3
1999 3
2000 2
2001 5
2002 6
2003 6
2004 4
2005 7
2006 5
2007 6
2008 9
2009 8
2010 8
2011 5
2012 5
2013 12
2014 9
2015 9
2016 14
2017 10
2018 8
2019 9
2020 12
2021 18
2022 23
2023 27
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Results by year

Filters applied: . Clear all
Page 1
Towards Circulating-Tumor DNA-Based Precision Medicine.
Hironaka-Mitsuhashi A, Sanchez Calle A, Ochiya T, Takayama S, Suto A. Hironaka-Mitsuhashi A, et al. Among authors: suto a. J Clin Med. 2019 Sep 2;8(9):1365. doi: 10.3390/jcm8091365. J Clin Med. 2019. PMID: 31480647 Free PMC article. Review.
Ring-opening fluorination of bicyclic azaarenes.
Komatsuda M, Suto A, Kondo H Jr, Takada H, Kato K, Saito B, Yamaguchi J. Komatsuda M, et al. Among authors: suto a. Chem Sci. 2021 Dec 21;13(3):665-670. doi: 10.1039/d1sc06273e. eCollection 2022 Jan 19. Chem Sci. 2021. PMID: 35173930 Free PMC article.
Sox5 and Th17 cell differentiation.
Suto A, Tanaka S, Nakajima H. Suto A, et al. Oncotarget. 2015 Aug 21;6(24):19952-3. doi: 10.18632/oncotarget.4784. Oncotarget. 2015. PMID: 26197269 Free PMC article. No abstract available.
Ring-Opening Fluorination of Isoxazoles.
Komatsuda M, Ohki H, Kondo H Jr, Suto A, Yamaguchi J. Komatsuda M, et al. Among authors: suto a. Org Lett. 2022 May 6;24(17):3270-3274. doi: 10.1021/acs.orglett.2c01149. Epub 2022 Apr 26. Org Lett. 2022. PMID: 35471036
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer.
Sanomachi T, Okuma HS, Kitadai R, Kawachi A, Yazaki S, Tokura M, Arakaki M, Saito A, Kita S, Yamamoto K, Maejima A, Kojima Y, Nishikawa T, Sudo K, Shimoi T, Noguchi E, Fujiwara Y, Sugino H, Shiino S, Suto A, Yoshida M, Yonemori K. Sanomachi T, et al. Among authors: suto a. Front Oncol. 2023 Mar 27;13:1157789. doi: 10.3389/fonc.2023.1157789. eCollection 2023. Front Oncol. 2023. PMID: 37051545 Free PMC article.
Defensive Venoms: Is Pain Sufficient for Predator Deterrence?
Niermann CN, Tate TG, Suto AL, Barajas R, White HA, Guswiler OD, Secor SM, Rowe AH, Rowe MP. Niermann CN, et al. Among authors: suto al. Toxins (Basel). 2020 Apr 17;12(4):260. doi: 10.3390/toxins12040260. Toxins (Basel). 2020. PMID: 32316477 Free PMC article.
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
Sasada S, Kondo N, Hashimoto H, Takahashi Y, Terata K, Kida K, Sagara Y, Ueno T, Anan K, Suto A, Kanbayashi C, Takahashi M, Nakamura R, Ishiba T, Tsuneizumi M, Nishimura S, Naito Y, Hara F, Shien T, Iwata H. Sasada S, et al. Among authors: suto a. Breast Cancer Res Treat. 2023 Dec;202(3):473-483. doi: 10.1007/s10549-023-07097-6. Epub 2023 Sep 9. Breast Cancer Res Treat. 2023. PMID: 37688665 Free PMC article.
227 results